Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus
- PMID: 1314465
- DOI: 10.1016/0042-6822(92)90771-g
Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus
Abstract
Sequence variation in the gp116 component of cytomegalovirus envelope glycoprotein B was examined in 11 clinical strains and compared with variation in gp55. The peptide variation in gp116 was found to be strongly clustered at codons 27-67, 440-460, and to a lesser extent at codons 181-194, 311-317, and 387-397. Strains adopted one of three to four peptide configurations at these loci, usually consistent with their gp55 sequence configuration. Two instances were observed of a sequence variation arising from recombination within gB. The limited, largely group-specific nature of variation in both gp116 and gp55 facilitates functional and immunologic analyses.
Similar articles
-
Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus.J Infect Dis. 1992 Sep;166(3):604-7. doi: 10.1093/infdis/166.3.604. J Infect Dis. 1992. PMID: 1323623
-
Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes.J Infect Dis. 1991 Jun;163(6):1229-34. doi: 10.1093/infdis/163.6.1229. J Infect Dis. 1991. PMID: 1709960
-
Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus.Virology. 1992 Nov;191(1):523-8. doi: 10.1016/0042-6822(92)90224-d. Virology. 1992. PMID: 1329336
-
Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.Virology. 1988 Nov;167(1):207-25. doi: 10.1016/0042-6822(88)90071-2. Virology. 1988. PMID: 2460994
-
Epidemiology of human cytomegalovirus strains through comparison of methodological approaches to explore gN variants.New Microbiol. 2009 Jan;32(1):1-10. New Microbiol. 2009. PMID: 19382663 Review.
Cited by
-
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.Infect Disord Drug Targets. 2011 Oct;11(5):504-13. doi: 10.2174/187152611797636668. Infect Disord Drug Targets. 2011. PMID: 21827431 Free PMC article. Review.
-
Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.J Virol. 1995 Nov;69(11):7015-22. doi: 10.1128/JVI.69.11.7015-7022.1995. J Virol. 1995. PMID: 7474121 Free PMC article.
-
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.NPJ Vaccines. 2024 Feb 20;9(1):38. doi: 10.1038/s41541-024-00821-3. NPJ Vaccines. 2024. PMID: 38378950 Free PMC article.
-
Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.Med Microbiol Immunol. 2019 Aug;208(3-4):415-429. doi: 10.1007/s00430-019-00600-1. Epub 2019 Mar 28. Med Microbiol Immunol. 2019. PMID: 30923898 Free PMC article. Review.
-
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses.J Virol. 2004 Oct;78(19):10755-64. doi: 10.1128/JVI.78.19.10755-10764.2004. J Virol. 2004. PMID: 15367642 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Other Literature Sources